Consort Medical plc (LON:CSRT) Insider Purchases £9,936 in Stock
Consort Medical plc (LON:CSRT) insider Ian James Nicholson purchased 1,350 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The stock was bought at an average price of GBX 736 ($9.62) per share, with a total value of £9,936 ($12,983.14).
Shares of LON:CSRT opened at GBX 736 ($9.62) on Friday. Consort Medical plc has a 1 year low of GBX 700 ($9.15) and a 1 year high of GBX 1,270 ($16.59). The business has a 50 day simple moving average of GBX 791.54 and a two-hundred day simple moving average of GBX 874.11. The firm has a market capitalization of $363.32 million and a PE ratio of 34.72. The company has a debt-to-equity ratio of 46.56, a current ratio of 1.63 and a quick ratio of 1.04.
The firm also recently announced a dividend, which will be paid on Friday, October 25th. Shareholders of record on Thursday, September 19th will be given a dividend of GBX 13.80 ($0.18) per share. This represents a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 19th. This is a positive change from Consort Medical’s previous dividend of $7.60. Consort Medical’s payout ratio is 1.32%.
Consort Medical Company Profile
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Further Reading: Gross Domestic Product (GDP)
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.